|
Istodax Approved for Cutaneous T-Cell Lymphoma
It's a disfiguring cancer affecting the skin
Fri Nov 06, 2009, 15:32
|
Story Tools
|
|
•
|
Printable
version
|
|
•
|
Nov 06, 2009 News
|
|
Related News Categories
| | • | Food & Drug Administration | | • | Drug Approvals | | • | Cancer: Leukemia |
Related News
| • | Formaldehyde May Endanger Funeral Workers - Nov 20, 2009 | • | Heartburn Drugs Can Thwart Popular Blood Thinner - Nov 17, 2009 | • | Qutenza Approved for Post-Shingles Nerve Pain - Nov 17, 2009 | • | Lysteda Approved for Heavy Menstrual Bleeding - Nov 16, 2009 | • | Another Swine Flu Vaccine Approved for Children - Nov 13, 2009 | • | FDA Questions Safety of Caffeinated Alcoholic Drinks - Nov 13, 2009 | • | Web Giants Urge FDA to Update Ad Guidelines - Nov 13, 2009 | • | Leukemia Drug May Help Some Ovarian Cancer Patients - Nov 12, 2009 | • | Trial Data on Anti-Seizure Drug Might Have Been Manipulated: Report - Nov 11, 2009 | • | Istodax Approved for Cutaneous T-Cell Lymphoma - Nov 06, 2009 | • | FDA Initiative Seeks to Reduce Accidental Overdoses - Nov 04, 2009 | • | FDA Issues Warning for Diabetes Drug - Nov 03, 2009 | • | Arzerra Approved for Chronic Lymphocytic Leukemia - Oct 27, 2009 | • | Sebelius: There Will Be Swine Flu Vaccine for All Who Want It - Oct 26, 2009 | • | Obama Declares Swine Flu a National Emergency - Oct 26, 2009 |
FRIDAY, Nov. 6 (HealthDay News) -- The Gloucester Pharmaceuticals drug Istodax (romidepsin) has been approved by the U.S. Food and Drug Administration to treat cutaneous T-cell lymphoma (CTCL) in people who have tried at least one prior systemic therapy, the drug's manufacturer said in a news release.
CTCL is a form of non-Hodgkin's lymphoma, a cancer of the germ-fighting lymphatic system. The cancerous cells of the skin can cause itchy, disfiguring patches, and the cancer may involve other organs including the lymph nodes, blood and viscera, the drug maker said.
Blood parameters should be carefully monitored while people take Istodax, and since it can harm a fetus, the drug shouldn't be taken by pregnant women, Gloucester said. Istodax also may interfere will some contraceptives that contain estrogen, the company warned.
Approval of Istodax followed two clinical studies of 167 patients, Gloucester said. The drug is expected to be available in January.
More information
There's more about this drug's history at the FDA.
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Today's Top News Stories | • | One in Four Teen Girls Have STDs - Nov 23, 2009, 12:00
Almost 20 percent get infected within one year of starting to have sex, CDC report says. | • | Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids - Nov 23, 2009, 09:00
Study found one more than doubled chances, while both increased risk eightfold. | • | Combo Treatment Beneficial in Biliary-Tract Cancer Study - Nov 23, 2009, 09:00
Adding drug to chemo regimen may improve patient outcomes, research suggests. | • | Genetic Variant Slows AIDS Progression - Nov 23, 2009, 09:00
HIV patients who have it take longer to get sick, study finds. | • | Weight May Not Drive Racial Disparities in Colon Cancer - Nov 23, 2009, 09:00
Co-existing illnesses also don't explain why more blacks die than whites, study finds. |
|
|
|
